Loading…
Employees: 2,691
Size Jiangsu Hanvo Safety Product (300952.SZ) is a China Health Care company (Medical Specialties) with a market value of $681M, the 3129th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥18.82 on 6 Nov 2026.
Performance Over six months the shares fell 21.4%, against -9.1% for the median peer and -16.4% for the China market (cap-weighted) — 6th lowest of 21 in its peer set.
Growth Revenue grew 6.5% over the last twelve months (peer median +9.1%); the operating margin is 7.5% (peer median 13.7%).
Valuation It trades at 47.6× forward earnings against a peer median of 19.8× (3rd most expensive of 16).
Capital Return on invested capital runs 1.4 points below its cost of capital (7.2% WACC).
Next results Next results expected around 16 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.35B | CN¥1.22B | CN¥1.27B | CN¥967M | CN¥889M |
| Revenue growth | — | -3% | +31% | +9% | — |
| Gross profit | CN¥400M | CN¥275M | CN¥265M | CN¥225M | CN¥210M |
| EBITDA | n/a | CN¥234M | CN¥201M | CN¥176M | CN¥153M |
| Net income | CN¥70.1M | CN¥102M | CN¥117M | CN¥106M | CN¥122M |
| Free cash flow | -CN¥178M | -CN¥381M | -CN¥229M | -CN¥113M | -CN¥128M |
| Capital expenditure | CN¥389M | CN¥580M | CN¥332M | CN¥216M | CN¥318M |
| Total debt | CN¥774M | CN¥579M | CN¥736M | CN¥285M | CN¥110M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300952.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +16.9% | -2.0% | 2nd highest of 21 |
| 6-month return | -21.4% | -9.1% | 6th lowest of 21 |
| Distance from 52-week high | -53.0% | -31.3% | 5th lowest of 21 |
| Revenue growth (TTM) | +6.5% | +9.1% | 11th highest of 21 |
| Operating margin | 7.5% | 13.7% | 8th lowest of 21 |
| Forward P/E | 47.6× | 19.8× | 3rd most expensive of 16 |
| ROIC minus cost of capital | -1.4 pp | +4.1 pp | 9th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jiangsu Hanvo Safety Product 300952.SZ | China | $681M | -21% | +6% | 8% | 47.6× | n/a | n/a |
| Beijing Chunlizhengda Medical Instruments 688236.SS | China | $684M | -21% | -13% | 31% | 19.1× | -5.4% | +2.2% |
| Japan Lifeline 7575.T | Japan | $685M | +16% | +6% | 19% | 14.1× | -9.7% | +2.9% |
| Shanghai Kinetic Medical 300326.SZ | China | $698M | -7% | -28% | 17% | 27.4× | 8.1% | -1.9% |
| AK Medical 1789.HK | Hong Kong | $664M | -26% | +16% | 26% | 10.8× | -11.4% | +6.7% |
| Shanghai Sanyou Medical 688085.SS | China | $700M | -21% | +15% | 4% | 50.9× | 29.1% | +6.8% |
| Pacific Biosciences of California PACB | United States | $701M | +60% | +2% | -102% | n/a | n/a | n/a |
| Livsmed 491000.KS | South Korea | $706M | -47% | +89% | -59% | n/a | n/a | n/a |
| Synektik SNT.WA | Poland | $713M | +16% | +50% | 24% | 11.8× | 0.1% | +40.3% |
| Cowealth Medical China 603122.SS | China | $648M | -28% | -18% | -5% | n/a | n/a | n/a |
| Mesa Laboratories MLAB | United States | $718M | +23% | +3% | 9% | 12.6× | 21.1% | +13.2% |
| SunMax Biotechnology 4728.TWO | Taiwan | $643M | +1% | +12% | 50% | n/a | -0.7% | +18.8% |
| SWS Hemodialysis Care 688410.SS | China | $723M | -12% | +31% | 19% | 24.1× | 16.7% | +25.9% |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $728M | -8% | +29% | 5% | 41.8× | 11.1% | +14.2% |
| Xvivo Perfusion XVIVO.ST | Sweden | $635M | -29% | +18% | 12% | 54.2× | 35.7% | +35.2% |
| QuidelOrtho QDEL | United States | $734M | -1% | -5% | -2% | 12.0× | n/a | n/a |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $741M | -5% | +12% | 18% | 16.1× | -2.1% | +11.8% |
| Shenzhen Lifotronic Technology 688389.SS | China | $749M | -11% | +14% | 13% | 32.4× | 13.5% | +13.3% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $750M | +177% | -14% | 3% | n/a | 33.5% | -0.6% |
| Hangzhou AGS MedTech 688581.SS | China | $617M | -16% | -18% | 33% | 19.8× | 1.7% | +27.8% |
| Doctorglasses Chain 300622.SZ | China | $757M | -10% | +6% | 14% | 24.5× | -2.4% | +15.7% |